# Stress Testing and Cardiac Magnetic Resonance

> **NCT00871260** · PHASE4 · COMPLETED · sponsor: **University of Chicago** · enrollment: 20 (actual)

## Conditions studied

- Coronary Disease

## Interventions

- **DRUG:** regadenoson

## Key facts

- **NCT ID:** NCT00871260
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2014-06-04
- **Final completion:** 2014-06-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00871260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00871260, "Stress Testing and Cardiac Magnetic Resonance". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT00871260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*